Acetaminophen vs Placebo for Postoperative Analgesia After Abdominal Surgery
- Sponsor
- Konya City Hospital
- Study ID
- NCT07720791
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pain, Postoperative
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Acetaminophen — DRUGIntervention 1: Acetaminophen (Type: Drug) Oral acetaminophen 1000 mg tablet, administered 30 minutes before surgery and every 6 hours postoperatively until 48 hours after surgery. Other Name(s): Paracetamol Intervention 2: Placebo (Type: Other / Drug) Oral placebo tablet, visually identical to the acetaminophen tablet, administered on the same schedule (30 minutes before surgery and every 6 hours postoperatively until 48 hours after surgery).
Study Details
This study investigates whether oral acetaminophen, when added to standard pain management, reduces opioid use and pain after major abdominal surgery, compared to a placebo (inactive pill). Patients undergoing planned abdominal surgery under general anesthesia will be randomly assigned to receive either acetaminophen or a placebo tablet before surgery and every 6 hours afterward for 48 hours, in addition to their usual pain medication. Researchers will measure how much opioid pain medication patients need, how much pain they report, and how satisfied they are with their pain control during the first two days after surgery. The goal is to determine whether oral acetaminophen provides a genuine benefit beyond placebo in reducing opioid use while maintaining adequate pain control.
Key Dates
- First listed
- Jul 22, 2026
- Start date
- Jul 15, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 15, 2027
- Completion
- Aug 1, 2027
Study Design
- Enrollment
- 1,504 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: AcetaminophenArm 1: Acetaminophen (Arm Type: Experimental) Participants will receive oral acetaminophen 1000 mg, administered 30 minutes before surgery and every 6 hours postoperatively for 48 hours.
- Placebo Comparator: PlaceboParticipants will receive a matching placebo tablet, administered 30 minutes before surgery and every 6 hours postoperatively for 48 hours.
Primary Outcome Measure
Total Postoperative Opioid Consumption [ Time Frame: 48 hours after surgery ]
Central Contacts
- Yasin Tire+905055367970
- Ayşenur Dostbil
Related Studies
- Continuous Infusions vs Scheduled Bolus InfusionsPHASE4 · Recruiting · Stanford University · Stanford, California
- Liposomal Bupivacaine Versus Plain Bupivacaine After Intercostal Injections For Pain Management After ThoracoscopyPHASE4 · Recruiting · Milton S. Hershey Medical Center · Hershey, Pennsylvania
- Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic SurgeryPHASE4 · Recruiting · Sanford Health · Fargo, North Dakota
- Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic SurgeryRecruiting · Stanford University · Redwood City, California